HeartSciences Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

HeartSciences Inc. reported Cash And Cash Equivalents At Carrying Value of $1.10 million for the year ending 2025.

  • HeartSciences Inc. showed a decrease of -81.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from HeartSciences Inc.'s annual report (Form 10-K), filed with the SEC on July 24, 2025.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), HeartSciences Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 19.6%.
  • Historical annual values: Fiscal year 2025: $1.10 million | Fiscal year 2024: $5.81 million | Fiscal year 2023: $1.66 million | Fiscal year 2022: $918.3 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: